MacroGenics
MGNX
#8794
Rank
NZ$0.42 B
Marketcap
NZ$6.66
Share price
5.35%
Change (1 day)
117.95%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.42 Billion

As of October 2026 MacroGenics has a market cap of NZ$0.42 Billion. This makes MacroGenics the world's 8794th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.42 B141.4%
2025NZ$0.17 B-51.08%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Oct 9th, 2026 the market cap of MacroGenics was reported to be:

NZ$0.42 Billion
by Nasdaq info icon info icon
NZ$0.42 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$287.21 B 67,557.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.873 T 441,117.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$399.66 B 94,045.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$334.00 B 78,579.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$640.09 B 150,681.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$215.19 B 50,590.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$3.26 B 668.69%๐Ÿ‡บ๐Ÿ‡ธ USA